Study to Evaluate the Drug-drug Interaction Between IY001 and IY002 in Healthy Adult Male Subjects.

Clinical trial NCT07322991 · COMPLETED

Trial details

NCT number: NCT07322991
Sponsor: Il-Yang Pharm. Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Male

Start date: 2025-10-14
Primary completion: 2025-12-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.